While President Biden is focused on expanding COVID-19 vaccination in the US, the battle over a proposal to waive intellectual property rights for COVID-19 vaccines has intensified. Biden said he would make a decision on the IP issue and also noted the actions the administration is taking to boost the global supply of vaccines.
The administration has already committed to send 60 million doses of AstraZeneca PLC’s COVID-19 vaccine to other countries, starting this month and into June. "That means of all the...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?